196 related articles for article (PubMed ID: 25336460)
1. Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents.
Freedman JC; Li J; Uzal FA; McClane BA
mBio; 2014 Oct; 5(5):e01994-14. PubMed ID: 25336460
[TBL] [Abstract][Full Text] [Related]
2. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
Freedman JC; McClane BA; Uzal FA
Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
[TBL] [Abstract][Full Text] [Related]
3. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
[TBL] [Abstract][Full Text] [Related]
4. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.
Harkness JM; Li J; McClane BA
Anaerobe; 2012 Oct; 18(5):546-52. PubMed ID: 22982043
[TBL] [Abstract][Full Text] [Related]
5. Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.
Gil C; Dorca-Arévalo J; Blasi J
PLoS One; 2015; 10(10):e0140321. PubMed ID: 26452234
[TBL] [Abstract][Full Text] [Related]
6. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.
Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW
Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825
[TBL] [Abstract][Full Text] [Related]
7. Amino acid residue Y196E substitution and C-terminal peptide synergistically alleviate the toxicity of Clostridium perfringens epsilon toxin.
Yao W; Kang L; Gao S; Zhuang X; Zhang T; Yang H; Ji B; Xin W; Wang J
Toxicon; 2015 Jun; 100():46-52. PubMed ID: 25912943
[TBL] [Abstract][Full Text] [Related]
8. Enterotoxemia produced by lambda toxin-positive
Acevedo HD; Schlesinger MS; Streitenberger N; Henderson E; Asin J; Beingesser J; Uzal FA
J Vet Diagn Invest; 2023 Jul; 35(4):448-451. PubMed ID: 37212504
[TBL] [Abstract][Full Text] [Related]
9. Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep.
Jiang Z; Chang J; Wang F; Qi Y; Li Y; Yu D; Yu L
Vaccine; 2020 Sep; 38(42):6553-6561. PubMed ID: 32788135
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of toxicity of Clostridium perfringens epsilon toxin.
Bokori-Brown M; Savva CG; Fernandes da Costa SP; Naylor CE; Basak AK; Titball RW
FEBS J; 2011 Dec; 278(23):4589-601. PubMed ID: 21518257
[TBL] [Abstract][Full Text] [Related]
11. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
[TBL] [Abstract][Full Text] [Related]
12. Clostridium perfringens epsilon prototoxin mutant rpETX
Du J; Wang T; Xu L; Wang C; Liu Y; Pan C; Chen X; Zhu Z; Luo Y; Yin C
Vaccine; 2023 Jul; 41(32):4762-4770. PubMed ID: 37357076
[TBL] [Abstract][Full Text] [Related]
13.
Kumar S; Behera SK; Gururaj K; Chaurasia A; Murmu S; Prabha R; Angadi UB; Pawaiya RS; Rai A
J Biomol Struct Dyn; 2024 Mar; 42(5):2257-2269. PubMed ID: 37129165
[TBL] [Abstract][Full Text] [Related]
14. Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens.
Dorca-Arévalo J; Pauillac S; Díaz-Hidalgo L; Martín-Satué M; Popoff MR; Blasi J
PLoS One; 2014; 9(7):e102417. PubMed ID: 25013927
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four techniques for the detection of Clostridium perfringens type D epsilon toxin in intestinal contents and other body fluids of sheep and goats.
Uzal FA; Kelly WR; Thomas R; Hornitzky M; Galea F
J Vet Diagn Invest; 2003 Mar; 15(2):94-9. PubMed ID: 12661718
[TBL] [Abstract][Full Text] [Related]
16. Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.
Theoret JR; Li J; Navarro MA; Garcia JP; Uzal FA; McClane BA
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038129
[TBL] [Abstract][Full Text] [Related]
17. Systematic evaluation of membrane-camouflaged nanoparticles in neutralizing Clostridium perfringens ε-toxin.
Xu J; Li D; Kang L; Liu T; Huang J; Li J; Lv J; Wang J; Gao S; Li Y; Yuan B; Zhao B; Wang J; Xin W
J Nanobiotechnology; 2023 Mar; 21(1):95. PubMed ID: 36932366
[TBL] [Abstract][Full Text] [Related]
18. Pathology and Pathogenesis of Brain Lesions Produced by
Finnie JW; Uzal FA
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012315
[No Abstract] [Full Text] [Related]
19. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.
Sakurai J; Nagahama M
Microb Pathog; 1986 Oct; 1(5):417-23. PubMed ID: 2907772
[TBL] [Abstract][Full Text] [Related]
20. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW
Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
